MiMedx Group (MDXG)
(Delayed Data from NSDQ)
$7.29 USD
-0.17 (-2.28%)
Updated Jul 18, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 28% (69 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | 0.08 | 7.43 | 61.00 |
Year Ago Quarter Estimate | 0.00 | 0.12 | 54.84 |
Next Quarter Estimate | 0.09 | 7.81 | 63.00 |
Next Year Estimate | 0.49 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 220.00 | 15.20 | 15.67 |
Next Year | 53.13 | 10.00 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 45.56 | -2.18 |
Price/Book (MRQ) | 6.91 | 2.16 |
Price/Cash Flow (MRFY) | 38.77 | 16.71 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 18.63% | -100.57% |
Return on Equity (TTM) | 39.42% | -49.27% |
Debt to Equity (MRQ) | NA | 0.13 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.